Literature DB >> 15299049

Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patients.

Arne-Jörn Lemke1, Stefan Markus Niehues, Norbert Hosten, Holger Amthauer, Michael Boehmig, Christian Stroszczynski, Torsten Rohlfing, Stefan Rosewicz, Roland Felix.   

Abstract

UNLABELLED: Differential diagnosis of pancreatic lesions still remains a problem. Whereas CT provides high spatial resolution, PET detects malignant lesions with high sensitivity. The objective of this study was to evaluate the clinical benefit of PET/CT image fusion in the diagnostic workup of pancreatic cancer.
METHODS: One hundred four patients with suspected pancreatic lesion underwent triple-phase multidetector CT and (18)F-FDG PET scanning. Voxel-based retrospective registration and fusion of CT and PET were performed with recently developed software. CT, PET, and fused images were assessed by 2 radiologists with regard to the detection of malignancies, possible infiltration of adjacent tissue or lymph nodes, or distant metastases.
RESULTS: Fusion of CT and PET images was technically successful in 96.2%. In 2 cases, paraaortic lymph node infiltration was detected only by image fusion; in a further 8 cases, lymph node metastases were confirmed with improved localization. In 5 patients, additional pancreatic tumors or distant metastases only suspected during PET scanning were confirmed. Image fusion improved the sensitivity of malignancy detection from 76.6% (CT) and 84.4% (PET) to 89.1% (image fusion). Compared with CT alone, image fusion increased the sensitivity of detecting tissue infiltration to 68.2%, but at the cost of decreased specificity.
CONCLUSION: The most important supplementary finding supplied by image fusion is a more precise correlation with focal tracer hot spots in PET. Image fusion improved the sensitivity of differentiating between benign and malignant pancreatic lesions with no significant change in specificity. All image modalities failed to stage lymph node involvement.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15299049

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  22 in total

1.  Combined PET/CT colonography: is this the way forward?

Authors:  A G Schreyer; R Kikinis
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

2.  Putting 'clear' into nuclear medicine: a decade of PET/CT development.

Authors:  Thomas Beyer; David W Townsend
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08       Impact factor: 9.236

Review 3.  Biology and management of pancreatic cancer.

Authors:  Paula Ghaneh; Eithne Costello; John P Neoptolemos
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

4.  The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma.

Authors:  Lujaien A Kadhim; Avani S Dholakia; Joseph M Herman; Richard L Wahl; Muhammad A Chaudhry
Journal:  J Radiat Oncol       Date:  2013-10-30

Review 5.  Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer.

Authors:  Xiao-Yi Wang; Feng Yang; Chen Jin; De-Liang Fu
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 6.  Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management.

Authors:  Nicolas C Buchs; Michael Chilcott; Pierre-Alexandre Poletti; Leo H Buhler; Philippe Morel
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

Review 7.  Positron emission tomography in hepatobiliary and pancreatic malignancies: a review.

Authors:  Billy Y Lan; Sandi A Kwee; Linda L Wong
Journal:  Am J Surg       Date:  2012-03-30       Impact factor: 2.565

8.  Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence.

Authors:  Wenjie Sun; Cheng N Leong; Zhen Zhang; Jiade J Lu
Journal:  Radiat Oncol       Date:  2010-04-15       Impact factor: 3.481

9.  Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound.

Authors:  Verena Schick; Christiane Franzius; Torsten Beyna; May Lin Oei; Jürgen Schnekenburger; Matthias Weckesser; Wolfram Domschke; Otmar Schober; Walter Heindel; Thorsten Pohle; Kai Uwe Juergens
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-15       Impact factor: 9.236

10.  The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.

Authors:  Maria-João Ribeiro; Nathalie Boddaert; Christine Bellanné-Chantelot; Sandrine Bourgeois; Vassili Valayannopoulos; Thierry Delzescaux; Francis Jaubert; Claire Nihoul-Fékété; Francis Brunelle; Pascale De Lonlay
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07-28       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.